New product intros [anlotinib dihydrochloride, brexanolone, dexamethasone punctum plug (new formulation), dupilumab (new indication), eculizumab (new indication), halobetasol propionate/tazarotene (new combination), selinexor]
Keyword(s):
Keyword(s):
Keyword(s):